Xeris Pharmaceuticals

$4.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.70%) Today

-$0.03 (-0.71%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, and ETFs commission-free!

About XERS

Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables.

CEO

Paul R. Edick

Employees

180

Headquarters

Chicago, Illinois

Founded

2005

Market Cap

290.40M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.65M

High Today

$4.29

Low Today

$4.16

Open Price

$4.24

Volume

816.06K

52 Week High

$7.94

52 Week Low

$1.56

XERS Earnings

-$1.23

-$0.82

-$0.41

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, Pre-Market